Loading…
COVID-19 associated myocarditis: A systematic review
Most COVID-19 infections result in a viral syndrome characterized by fever, cough, shortness of breath, and myalgias. A small but significant proportion of patients develop severe COVID-19 resulting in respiratory failure. Many of these patients also develop multi-organ dysfunction as a byproduct of...
Saved in:
Published in: | The American journal of emergency medicine 2022-01, Vol.51, p.150-155 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3 |
container_end_page | 155 |
container_issue | |
container_start_page | 150 |
container_title | The American journal of emergency medicine |
container_volume | 51 |
creator | Haussner, William DeRosa, Antonio P. Haussner, Danielle Tran, Jacqueline Torres-Lavoro, Jane Kamler, Jonathan Shah, Kaushal |
description | Most COVID-19 infections result in a viral syndrome characterized by fever, cough, shortness of breath, and myalgias. A small but significant proportion of patients develop severe COVID-19 resulting in respiratory failure. Many of these patients also develop multi-organ dysfunction as a byproduct of their critical illness. Although heart failure can be a part of this, there also appears to be a subset of patients who have primary cardiac collapse from COVID-19.
Conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
Our review demonstrates two distinct etiologies of primary acute heart failure in surprisingly equal incidence in patients with COVID-19: viral myocarditis and Takotsubo cardiomyopathy. COVID myocarditis, Takotsubo cardiomyopathy, and severe COVID-19 can be clinically indistinguishable. All can present with dyspnea and evidence of cardiac injury, although in myocarditis and Takotsubo this is due to primary cardiac dysfunction as compared to respiratory failure in severe COVID-19.
COVID-19-associated myocarditis differs from COVID-19 respiratory failure by an early shock state. However, not all heart failure from COVID-19 is from direct viral infection; some patient's develop takotsubo cardiomyopathy. Regardless of etiology, steroids may be a beneficial treatment, similar to other critically ill COVID-19 patients. Evidence of cardiac injury in the form of ECG changes or elevated troponin in patients with COVID-19 should prompt providers to consider concurrent myocarditis.
•COVID-19 complications can include myocardial injury, thrombotic events and heart failure.•Patients with COVID-19-associated myocarditis had similar risk factors to those with severe COVID-19.•Evidence of cardiac injury in patients with COVID-19 should urge providers to consider concurrent myocarditis. |
doi_str_mv | 10.1016/j.ajem.2021.10.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8531234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735675721008354</els_id><sourcerecordid>2608090519</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3</originalsourceid><addsrcrecordid>eNp9kU1LHEEQhptgiKvJH_AQBrzkMpv-_hARZGMSQfAiuTa9PdWmh51p0z1r2H-fHtZI9JBTN1VPvVS9L0InBC8JJvJzv3Q9DEuKKamFJcbkDVoQwWiriSIHaIEVE61UQh2io1L6ChAu-Dt0yLhiRku9QHx1--P6S0tM40pJProJumbYJe9yF6dYzprLpuzKBIObom8yPEb4_R69DW5T4MPTe4zuvl7drb63N7ffrleXN63nmk1t11EVDJfSc4GVWa8D1wGcpPXP6m6G6LWSgbPghVJBUWCgPA-h08CIY8foYi_7sF0P0HkYp-w29iHHweWdTS7al50x_rT36dFqwQhlvAp8ehLI6dcWymSHWDxsNm6EtC2WCsOpkYabip6-Qvu0zWO9zlKJNTZYkJmie8rnVEqG8LwMwXbOxPZ2zsTOmcy1ankd-vjvGc8jf0OowPkegOpl9Tfb4iOMHrqYwU-2S_F_-n8AzZacMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2608090519</pqid></control><display><type>article</type><title>COVID-19 associated myocarditis: A systematic review</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Haussner, William ; DeRosa, Antonio P. ; Haussner, Danielle ; Tran, Jacqueline ; Torres-Lavoro, Jane ; Kamler, Jonathan ; Shah, Kaushal</creator><creatorcontrib>Haussner, William ; DeRosa, Antonio P. ; Haussner, Danielle ; Tran, Jacqueline ; Torres-Lavoro, Jane ; Kamler, Jonathan ; Shah, Kaushal</creatorcontrib><description>Most COVID-19 infections result in a viral syndrome characterized by fever, cough, shortness of breath, and myalgias. A small but significant proportion of patients develop severe COVID-19 resulting in respiratory failure. Many of these patients also develop multi-organ dysfunction as a byproduct of their critical illness. Although heart failure can be a part of this, there also appears to be a subset of patients who have primary cardiac collapse from COVID-19.
Conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
Our review demonstrates two distinct etiologies of primary acute heart failure in surprisingly equal incidence in patients with COVID-19: viral myocarditis and Takotsubo cardiomyopathy. COVID myocarditis, Takotsubo cardiomyopathy, and severe COVID-19 can be clinically indistinguishable. All can present with dyspnea and evidence of cardiac injury, although in myocarditis and Takotsubo this is due to primary cardiac dysfunction as compared to respiratory failure in severe COVID-19.
COVID-19-associated myocarditis differs from COVID-19 respiratory failure by an early shock state. However, not all heart failure from COVID-19 is from direct viral infection; some patient's develop takotsubo cardiomyopathy. Regardless of etiology, steroids may be a beneficial treatment, similar to other critically ill COVID-19 patients. Evidence of cardiac injury in the form of ECG changes or elevated troponin in patients with COVID-19 should prompt providers to consider concurrent myocarditis.
•COVID-19 complications can include myocardial injury, thrombotic events and heart failure.•Patients with COVID-19-associated myocarditis had similar risk factors to those with severe COVID-19.•Evidence of cardiac injury in patients with COVID-19 should urge providers to consider concurrent myocarditis.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/j.ajem.2021.10.001</identifier><identifier>PMID: 34739868</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Asthma ; Biopsy ; Calcium-binding protein ; Cardiac catheterization ; Cardiomyopathy ; Congestive heart failure ; Coronaviruses ; Cough ; COVID-19 ; COVID-19 - complications ; Diabetes ; Dyspnea ; Ejection fraction ; EKG ; Emergency medical care ; Etiology ; Fever ; Heart failure ; Heart Failure - virology ; Humans ; Hypertension ; Intubation ; Mortality ; Myocarditis ; Myocarditis - virology ; Patients ; Pneumonia ; Primary cardiac collapse ; Respiration ; Respiratory failure ; Respiratory Insufficiency - virology ; Risk Factors ; Severe acute respiratory syndrome coronavirus 2 ; Steroid hormones ; Steroids ; Systematic review ; Takotsubo cardiomyopathy ; Takotsubo Cardiomyopathy - virology ; Troponin</subject><ispartof>The American journal of emergency medicine, 2022-01, Vol.51, p.150-155</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><rights>2021. Elsevier Inc.</rights><rights>2021 Elsevier Inc. All rights reserved. 2021 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3</citedby><cites>FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34739868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haussner, William</creatorcontrib><creatorcontrib>DeRosa, Antonio P.</creatorcontrib><creatorcontrib>Haussner, Danielle</creatorcontrib><creatorcontrib>Tran, Jacqueline</creatorcontrib><creatorcontrib>Torres-Lavoro, Jane</creatorcontrib><creatorcontrib>Kamler, Jonathan</creatorcontrib><creatorcontrib>Shah, Kaushal</creatorcontrib><title>COVID-19 associated myocarditis: A systematic review</title><title>The American journal of emergency medicine</title><addtitle>Am J Emerg Med</addtitle><description>Most COVID-19 infections result in a viral syndrome characterized by fever, cough, shortness of breath, and myalgias. A small but significant proportion of patients develop severe COVID-19 resulting in respiratory failure. Many of these patients also develop multi-organ dysfunction as a byproduct of their critical illness. Although heart failure can be a part of this, there also appears to be a subset of patients who have primary cardiac collapse from COVID-19.
Conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
Our review demonstrates two distinct etiologies of primary acute heart failure in surprisingly equal incidence in patients with COVID-19: viral myocarditis and Takotsubo cardiomyopathy. COVID myocarditis, Takotsubo cardiomyopathy, and severe COVID-19 can be clinically indistinguishable. All can present with dyspnea and evidence of cardiac injury, although in myocarditis and Takotsubo this is due to primary cardiac dysfunction as compared to respiratory failure in severe COVID-19.
COVID-19-associated myocarditis differs from COVID-19 respiratory failure by an early shock state. However, not all heart failure from COVID-19 is from direct viral infection; some patient's develop takotsubo cardiomyopathy. Regardless of etiology, steroids may be a beneficial treatment, similar to other critically ill COVID-19 patients. Evidence of cardiac injury in the form of ECG changes or elevated troponin in patients with COVID-19 should prompt providers to consider concurrent myocarditis.
•COVID-19 complications can include myocardial injury, thrombotic events and heart failure.•Patients with COVID-19-associated myocarditis had similar risk factors to those with severe COVID-19.•Evidence of cardiac injury in patients with COVID-19 should urge providers to consider concurrent myocarditis.</description><subject>Asthma</subject><subject>Biopsy</subject><subject>Calcium-binding protein</subject><subject>Cardiac catheterization</subject><subject>Cardiomyopathy</subject><subject>Congestive heart failure</subject><subject>Coronaviruses</subject><subject>Cough</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>Diabetes</subject><subject>Dyspnea</subject><subject>Ejection fraction</subject><subject>EKG</subject><subject>Emergency medical care</subject><subject>Etiology</subject><subject>Fever</subject><subject>Heart failure</subject><subject>Heart Failure - virology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Intubation</subject><subject>Mortality</subject><subject>Myocarditis</subject><subject>Myocarditis - virology</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Primary cardiac collapse</subject><subject>Respiration</subject><subject>Respiratory failure</subject><subject>Respiratory Insufficiency - virology</subject><subject>Risk Factors</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Steroid hormones</subject><subject>Steroids</subject><subject>Systematic review</subject><subject>Takotsubo cardiomyopathy</subject><subject>Takotsubo Cardiomyopathy - virology</subject><subject>Troponin</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kU1LHEEQhptgiKvJH_AQBrzkMpv-_hARZGMSQfAiuTa9PdWmh51p0z1r2H-fHtZI9JBTN1VPvVS9L0InBC8JJvJzv3Q9DEuKKamFJcbkDVoQwWiriSIHaIEVE61UQh2io1L6ChAu-Dt0yLhiRku9QHx1--P6S0tM40pJProJumbYJe9yF6dYzprLpuzKBIObom8yPEb4_R69DW5T4MPTe4zuvl7drb63N7ffrleXN63nmk1t11EVDJfSc4GVWa8D1wGcpPXP6m6G6LWSgbPghVJBUWCgPA-h08CIY8foYi_7sF0P0HkYp-w29iHHweWdTS7al50x_rT36dFqwQhlvAp8ehLI6dcWymSHWDxsNm6EtC2WCsOpkYabip6-Qvu0zWO9zlKJNTZYkJmie8rnVEqG8LwMwXbOxPZ2zsTOmcy1ankd-vjvGc8jf0OowPkegOpl9Tfb4iOMHrqYwU-2S_F_-n8AzZacMg</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Haussner, William</creator><creator>DeRosa, Antonio P.</creator><creator>Haussner, Danielle</creator><creator>Tran, Jacqueline</creator><creator>Torres-Lavoro, Jane</creator><creator>Kamler, Jonathan</creator><creator>Shah, Kaushal</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>COVID-19 associated myocarditis: A systematic review</title><author>Haussner, William ; DeRosa, Antonio P. ; Haussner, Danielle ; Tran, Jacqueline ; Torres-Lavoro, Jane ; Kamler, Jonathan ; Shah, Kaushal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Asthma</topic><topic>Biopsy</topic><topic>Calcium-binding protein</topic><topic>Cardiac catheterization</topic><topic>Cardiomyopathy</topic><topic>Congestive heart failure</topic><topic>Coronaviruses</topic><topic>Cough</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>Diabetes</topic><topic>Dyspnea</topic><topic>Ejection fraction</topic><topic>EKG</topic><topic>Emergency medical care</topic><topic>Etiology</topic><topic>Fever</topic><topic>Heart failure</topic><topic>Heart Failure - virology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Intubation</topic><topic>Mortality</topic><topic>Myocarditis</topic><topic>Myocarditis - virology</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Primary cardiac collapse</topic><topic>Respiration</topic><topic>Respiratory failure</topic><topic>Respiratory Insufficiency - virology</topic><topic>Risk Factors</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Steroid hormones</topic><topic>Steroids</topic><topic>Systematic review</topic><topic>Takotsubo cardiomyopathy</topic><topic>Takotsubo Cardiomyopathy - virology</topic><topic>Troponin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haussner, William</creatorcontrib><creatorcontrib>DeRosa, Antonio P.</creatorcontrib><creatorcontrib>Haussner, Danielle</creatorcontrib><creatorcontrib>Tran, Jacqueline</creatorcontrib><creatorcontrib>Torres-Lavoro, Jane</creatorcontrib><creatorcontrib>Kamler, Jonathan</creatorcontrib><creatorcontrib>Shah, Kaushal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haussner, William</au><au>DeRosa, Antonio P.</au><au>Haussner, Danielle</au><au>Tran, Jacqueline</au><au>Torres-Lavoro, Jane</au><au>Kamler, Jonathan</au><au>Shah, Kaushal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 associated myocarditis: A systematic review</atitle><jtitle>The American journal of emergency medicine</jtitle><addtitle>Am J Emerg Med</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>51</volume><spage>150</spage><epage>155</epage><pages>150-155</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><abstract>Most COVID-19 infections result in a viral syndrome characterized by fever, cough, shortness of breath, and myalgias. A small but significant proportion of patients develop severe COVID-19 resulting in respiratory failure. Many of these patients also develop multi-organ dysfunction as a byproduct of their critical illness. Although heart failure can be a part of this, there also appears to be a subset of patients who have primary cardiac collapse from COVID-19.
Conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
Our review demonstrates two distinct etiologies of primary acute heart failure in surprisingly equal incidence in patients with COVID-19: viral myocarditis and Takotsubo cardiomyopathy. COVID myocarditis, Takotsubo cardiomyopathy, and severe COVID-19 can be clinically indistinguishable. All can present with dyspnea and evidence of cardiac injury, although in myocarditis and Takotsubo this is due to primary cardiac dysfunction as compared to respiratory failure in severe COVID-19.
COVID-19-associated myocarditis differs from COVID-19 respiratory failure by an early shock state. However, not all heart failure from COVID-19 is from direct viral infection; some patient's develop takotsubo cardiomyopathy. Regardless of etiology, steroids may be a beneficial treatment, similar to other critically ill COVID-19 patients. Evidence of cardiac injury in the form of ECG changes or elevated troponin in patients with COVID-19 should prompt providers to consider concurrent myocarditis.
•COVID-19 complications can include myocardial injury, thrombotic events and heart failure.•Patients with COVID-19-associated myocarditis had similar risk factors to those with severe COVID-19.•Evidence of cardiac injury in patients with COVID-19 should urge providers to consider concurrent myocarditis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34739868</pmid><doi>10.1016/j.ajem.2021.10.001</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-6757 |
ispartof | The American journal of emergency medicine, 2022-01, Vol.51, p.150-155 |
issn | 0735-6757 1532-8171 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8531234 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Asthma Biopsy Calcium-binding protein Cardiac catheterization Cardiomyopathy Congestive heart failure Coronaviruses Cough COVID-19 COVID-19 - complications Diabetes Dyspnea Ejection fraction EKG Emergency medical care Etiology Fever Heart failure Heart Failure - virology Humans Hypertension Intubation Mortality Myocarditis Myocarditis - virology Patients Pneumonia Primary cardiac collapse Respiration Respiratory failure Respiratory Insufficiency - virology Risk Factors Severe acute respiratory syndrome coronavirus 2 Steroid hormones Steroids Systematic review Takotsubo cardiomyopathy Takotsubo Cardiomyopathy - virology Troponin |
title | COVID-19 associated myocarditis: A systematic review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A29%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20associated%20myocarditis:%20A%20systematic%20review&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Haussner,%20William&rft.date=2022-01-01&rft.volume=51&rft.spage=150&rft.epage=155&rft.pages=150-155&rft.issn=0735-6757&rft.eissn=1532-8171&rft_id=info:doi/10.1016/j.ajem.2021.10.001&rft_dat=%3Cproquest_pubme%3E2608090519%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-dd27f9466c45079bbf48fea6279b3073918b76f43fc577f72e3e7c4ffd8e31a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2608090519&rft_id=info:pmid/34739868&rfr_iscdi=true |